Authors: XYNOGALOS S PETRAKI K KOMPOROZOS V PETRAKI C SKREKAS G PAPAKONSTANTINOU E VASLAMATZIS M ALEXOPOULOS CG

Citation: S. Xynogalos et al., BC12, P53 ONCOPROTEINS AND KI67 PROLIFERATION INDEX EXPRESSION IN COLORECTAL-CANCER (CRC), Annals of oncology, 9, 1998, pp. 176-176

Authors: VASLAMATZIS M PETRAKI C PETRAKI K PAPAKONSTANTINOU E GREGORAKIS A PARASKEVAKOU H DAVARIS P SOTSIOU F ALEXOPOULOS C

Citation: M. Vaslamatzis et al., SMALL-CELL CARCINOMA OF THE URINARY-BLADDER - CLINICAL, CLINICOPATHOLOGICAL, IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL CHARACTERISTICS IN 5 CASES, Annals of oncology, 9, 1998, pp. 310-310

Authors: VASLAMATZIS M XYNOGALOS S RONTOGIANNI D VARTHALITIS J MESISKLIS P VAMVOUKA C ALEXOPOULOS CG

Citation: M. Vaslamatzis et al., DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND DISTRIBUTION OF HISTOLOGICAL SUBTYPES IN 196 PATIENTS (PTS) - THE EXPERIENCE OF THE DEPARTMENT OFMEDICAL ONCOLOGY, EVANGELISMOS-HOSPITAL, ATHENS, GREECE, Annals of oncology, 9, 1998, pp. 513-513

Authors: VASLAMATZIS M PETRAKI C PAPACHRISTODOULOU A PAPAYANNI E ALEXOPOULOS CG

Citation: M. Vaslamatzis et al., PROGNOSTIC-SIGNIFICANCE OF VARIOUS IMMUNOHISTOCHEMICAL MARKERS IN INVASIVE UROTHELIAL CANCER OF THE BLADDER (UCCB), European journal of cancer, 31A, 1995, pp. 1164-1164

Authors: XYNAGALOS S VASLAMATZIS M ALEXOPOULOS CG

Citation: S. Xynagalos et al., ONDANSETRON (ODS) PLUS METOCLOPRAMIDE (MTP) PLUS DEXAMETHASONE (DXM) VS ONDANSETRON PLUS DEXAMETHASONE DURING CDDP BASED CHEMOTHERAPY (CT), European journal of cancer, 31A, 1995, pp. 1252-1252

Authors: ECONOMOPOULOS T STATHAKIS N ALEXOPOULOS C PAVLIDIS N CONSTANTINIDOU M BRIASSOULIS E PAPAGEORGIOU E DERVENOULAS J PAPPA V VASLAMATZIS M RAPTIS S

Citation: T. Economopoulos et al., 2ND MALIGNANCIES FOLLOWING TREATMENT FOR HODGKINS-DISEASE - A GREEK EXPERIENCE, Haematologica, 79(3), 1994, pp. 273-276